CleaRank Financial AI • AI-powered analysis using real-time market data from TwelveData
Analysis reviewed by Ryan Brothwell, Financial Journalist. Data refreshed daily. Not financial advice.
QuidelOrtho Corporation (QDEL) is trading at $13.87, below its 200-day simple moving average of $17.34, indicating a bearish long-term trend. The company's recent earnings report on August 6, 2026, showed an EPS beat of $0.13 against an estimate of -$0.05, a 360% surprise, though the stock reacted negatively with a -24.69% price change. This follows a pattern of mixed earnings performance, with a significant miss in the prior quarter. Despite the current price action, insiders have demonstrated conviction, being net buyers with $1.2M in total purchases versus $112K in total sales across recent filings. This moderate buying signal, coupled with a positive RSI status of 'BULLISH' at 62.93, suggests underlying support. However, the company faces significant revenue challenges, with current year revenue estimates showing a -7.00% decline and next quarter revenue projected to fall 8.00% year-over-year. The median analyst price target of $12.00 also implies a -13.5% downside from the current price, reflecting analyst caution.
QDEL at a glance
QuidelOrtho Corporation (QDEL): Hold, 42/100 on CleaRank's AI score.
TrendMixed: the price is above its 50-day but below its 200-day moving average ($12.98 and $17.34).
InsidersInsiders sold $112K and bought $1.2M over the last 18 months.
As of October 14, 2026, QuidelOrtho Corporation (QDEL) trades at $13.87. Wall Street's consensus target is $12.00 across 3 analysts. The 14-day RSI (daily closes) is 63, showing bullish momentum without being overbought, and the price is above its 50-day simple moving average of $12.98.
Figures as of October 14, 2026.
Only on CleaRank
Figures we compute ourselves from QDEL's own price, earnings and insider-filing history. Tap one to see it in context.
On price-to-sales, the yardstick used here in place of P/E, QDEL trades at 0.3616x, far below the sector average of 3.70x.
QDEL Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
In the last 2 quarters, QDEL beat the analyst estimate 1 time; the stock fell in the first session after 1 of those beats.
QDEL earnings surprises and the stock's reaction
Report
EPS estimate
EPS actual
Surprise
First session
5 sessions
Aug 6, 2026
-$0.05
$0.13
+360.00%
-24.69%
-7.54%
May 5, 2026
$0.36
-$0.04
-111.11%
-6.00%
-4.63%
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
As of October 14, 2026, QDEL has beaten the analyst EPS estimate in 1 of its last 2 reported quarters and fell in the first trading session after 1 of it; its latest report, on August 6, 2026, came in 360.00% above the estimate and the stock moved -24.69% in the first session.
QDEL Analysis
Company's Health3/5
12-Month Analyst Target-13.48% below price
Median of 3 analysts (12-month)
$12.00
AI Analyst Consensus ScoreHold
Volume on QuidelOrtho Corporation (QDEL) has been below average, with the latest volume at 2,145,471 compared to an average of 2,745,827, a decrease of 21.9%. The stock is currently trading above its 50-day simple moving average of $12.98 and its 20-day exponential moving average of $12.37, suggesting some short-term positive momentum. The 14-day RSI is at 62.93, indicating bullish momentum. However, QDEL is trading below its 200-day simple moving average of $17.34, which acts as resistance and points to a bearish long-term trend. Key support levels are near the 50-day SMA at $12.98, while resistance is found at the 200-day SMA at $17.34. The combination of short-term bullish indicators and a longer-term bearish trend suggests a period of consolidation or potential reversal is possible, contingent on future earnings and market sentiment.
ProTips
Consider the mixed analyst ratings and the median price target of $12.00 when assessing potential entry points, as it suggests limited upside from current levels.
Given the stock's position below the 200-day moving average, risk management strategies such as setting stop-loss orders near the 50-day SMA ($12.98) could be prudent.
Key Catalysts
BullishModerate Insider Buying Activity
Insiders have demonstrated conviction by being net buyers, with $1.2M in total purchases versus $112K in sales across recent filings, signaling potential confidence in the company's future prospects.
Source: Insider Trading Data
BullishPositive EPS Surprise in Latest Report
The earnings report on August 6, 2026, showed an EPS of $0.13 against an estimate of -$0.05, a significant 360% beat, indicating potential operational improvements.
Source: Earnings Report
BearishDeclining Revenue Projections
Revenue estimates for the next quarter show an 8.00% year-over-year decline, and current year revenue is projected to fall 7.00%, indicating ongoing top-line challenges.
Source: Analyst Estimates
BearishBelow 200-Day Moving Average
The stock is trading below its 200-day simple moving average of $17.34, which acts as resistance and suggests a bearish long-term trend.
Source: Technical Analysis
NeutralMixed Analyst Ratings and Price Targets
The current Wall Street consensus is 'Hold' with a median price target of $12.00, implying a -13.5% downside, reflecting analyst caution despite some positive signals.
Source: Wall Street Consensus
Market Outlook
The base case for QuidelOrtho Corporation (QDEL) over the next 6-12 months suggests a challenging environment, with the median analyst price target at $12.00, implying a downside from the current price. The company is expected to continue facing revenue headwinds, with projected year-over-year declines in the current and next quarters. Forward-looking growth estimates for next year are positive at 86.2%, but this follows a significant contraction in the current year. Potential catalysts for a turnaround include continued insider buying and positive surprises in future earnings reports, which could shift analyst sentiment. However, risks remain substantial, including the company's persistent unprofitability, high leverage, and the bearish technical signal of trading below the 200-day moving average. A failure to demonstrate sustained revenue growth and a path to profitability could lead to further price depreciation.
Key Statistics
Market Cap
951.14M
P/E Ratio
N/A (Negative EPS)
EPS (TTM)
-15.39
Dividend Yield
0.00%
52 Week High
35.58
52 Week Low
9.92
As of October 14, 2026, QDEL trades at $13.87, with a market value of $951.14M and no P/E ratio (its trailing earnings are negative).
QuidelOrtho Corporation (QDEL) exhibits a price-to-sales ratio of 0.36, which is significantly below the sector median of 3.7, indicating a potential valuation discount. However, the company is currently loss-making, with a negative EPS of -15.39 and a net profit margin of -39.20%, faring worse than the sector median ROE of 6.9%. The debt-to-equity ratio stands at 1.73, which is higher than the sector average, suggesting a more leveraged balance sheet. Despite the negative profitability, the company's revenue growth has been positive at 2.8%, though this is below the sector median of 8.1%. The current valuation appears attractive on a price-to-sales basis, but this is overshadowed by persistent losses and a higher debt load compared to industry peers. The forward revenue growth estimates for next year are projected at a modest 2.00%, indicating a slow recovery.
Earnings & Growth Analysis
QuidelOrtho Corporation (QDEL) reported an EPS surprise of 360% on August 6, 2026, with actual EPS of $0.13 against an estimate of -$0.05. This positive surprise was met with a significant stock price decline of -24.69%. The prior quarter's earnings on May 5, 2026, also showed a substantial miss, with actual EPS of -$0.04 against an estimate of $0.36, a -111.11% surprise, leading to a -6% price drop. This inconsistent earnings performance highlights ongoing volatility in profitability.
Key Risks
QuidelOrtho Corporation (QDEL) faces significant risks including persistent unprofitability, with a negative EPS and profit margin, and a higher-than-sector-average debt-to-equity ratio of 1.73. The stock is also trading below its 200-day moving average, indicating a bearish long-term trend, and faces declining revenue projections for the current and next quarters. Also, the median analyst price target of $12.00 suggests a potential downside from the current price.
Technical Indicators i
RSI (14-day)
62.93
MACD (12, 26)
0.227
SMA (50-day)
12.98
SMA (200-day)
17.34
Technical RatingBullish
RSI
Bullish
SMA Cross
Bearish
Price vs SMA
Bullish
MACD
Bullish
Moving averages show a lagging Death Cross (50-day: $12.98, 200-day: $17.34), price sits above the 50-day SMA but below the 200-day SMA - a mixed posture.
As of October 14, 2026, with QDEL at $13.87, its 14-day RSI is 62.9 (showing bullish momentum without being overbought), its 50-day simple moving average is $12.98 and its 200-day is $17.34.
Calculated by CleaRank on daily closes as of October 14, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)+0.38
Weak correlation
Nasdaq 100 (QQQ)+0.34
Weak correlation
Bitcoin (BTC)+0.07
Weak correlation
Gold (XAU)+0.06
Weak correlation
As of October 14, 2026, QDEL's 1-year correlation of daily returns is +0.38 with S&P 500 (SPY), +0.34 with Nasdaq 100 (QQQ), +0.07 with Bitcoin (BTC) and +0.06 with gold (XAU).
Check Custom Correlation
How does any other asset move with QDEL? One year of daily closes, Pearson correlation.
Try
QDEL Wall Street View
12-month price targets
Low $12.00Median $12.00 (-13.5%)High $20.00
Ratings
Buy 1Hold 1Sell 13 months ago: 1 of 5 buy
Recent rating actions
Recent analyst rating actions on QDEL
Date
Firm
Action
Rating
Jul 8, 2026
Citigroup
Maintains
Neutral
Jul 1, 2026
JP Morgan
Maintains
Underweight
May 7, 2026
Jefferies
Downgrade
Hold
May 6, 2026
Citigroup
Maintains
Neutral
As of October 14, 2026, 3 Wall Street analysts cover QDEL: 1 rate it a buy or strong buy, 1 a hold and 1 a sell or strong sell. Their 12-month price targets range from $12.00 to $20.00, with a median of $12.00, 13.5% below the price of $13.87.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
QDEL Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative2%Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Entry Strategies pick an entry style
Conservative
$13.73
Slight discount to current
Wait for small dip
Aggressive
$13.87
At current price
Enter now if confident
Risk Management
STOP LOSS
$12.21
MAX LOSS
-11.1%
Volatility-Adjusted Stop Loss
Calculated based on RSI (62.9) and current market volatility
QDEL moves about 4.2% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Growth of $10,000
A $10,000 investment in QDEL in October 2016 would be worth about $6,772 today, compared with about $36,506 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
QDEL Drawdowns & Recovery
Worst fall, last 10 years
-96.3%
August 2020 to September 2026
Recovery
Not yet
still 95.3% below the August 2020 peak
From the 10-year high
-95.3%
highest close, August 2020
1-year holds that gained
34%
of every 1-year window
As of October 14, 2026, QDEL's worst peak-to-trough fall over the last 10 years was -96.3% (August 2020 to September 2026); it is still 95.3% below that peak, and 34% of 1-year holding periods ended with a gain.
From weekly closing values. A drawdown is the fall from the highest value reached so far to a later low.
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in QDEL today could grow to about $10,935 by 2036 in the base case, with a 90th-percentile outcome near $82,959 and a 10th-percentile outcome around $1,441. Projections are statistical simulations, not guarantees.
QDEL Stock Price Prediction: 2030
CleaRank's simulation projects a price near $14.37 for QDEL by 2030 in the base case, from $13.87 today (1.0x over 4 years). The 10th-percentile path ends near $3.99. These are outcomes of a Monte Carlo simulation run on QDEL's historical return distribution, not price targets, and they assume no dividends are reinvested.
QDEL simulated price paths by year
Year
10th percentile
Base case
90th percentile
2027
$7.37
$13.99
$26.56
2028
$5.71
$14.12
$34.95
2029
$4.70
$14.25
$43.23
2030
$3.99
$14.37
$51.78
2031
$3.46
$14.50
$60.78
Method: a lognormal simulation of QDEL's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
As of October 14, 2026, QDEL insiders reported 1 open-market sale worth $112K and 8 open-market purchases worth $1.2M over the last 18 months; grants and option exercises are not counted.
Recent insider transactions in QDEL
Date
Insider
Type
Shares
Value
Aug 14, 2026
HANSON BRYAN MICHAEL
Officer
Grant
446
-
Jul 1, 2026
HANSON BRYAN MICHAEL
Officer
Grant
5.8K
-
Jun 5, 2026
BUECHLER KENNETH F
Director
Grant
2.2K
-
Jun 5, 2026
BUECHLER KENNETH F
Director
Option
1.7K
$23.8K
Jun 5, 2026
MICHAEL EDWARD L
Director
Grant
1.3K
-
Jun 5, 2026
MICHAEL EDWARD L
Director
Option
963
$13.8K
Jun 5, 2026
POLAN MARY LAKE PH.D
Director
Grant
973
-
Jun 5, 2026
POLAN MARY LAKE PH.D
Director
Option
749
$10.7K
Jun 5, 2026
WIDDER KENNETH JON M.D.
Director
Option
910
$13.0K
Jun 5, 2026
WIDDER KENNETH JON M.D.
Director
Grant
1.2K
-
Page 1 of 1
Frequently Asked Questions
How has QuidelOrtho Corporation (QDEL) performed in recent earnings reports?
QuidelOrtho Corporation (QDEL) recently reported an EPS beat on August 6, 2026 ($0.13 actual vs. -$0.05 estimate), but the stock fell 24.69%. The previous quarter also saw a significant EPS miss, indicating inconsistent earnings performance.
What are the key risks facing QuidelOrtho Corporation (QDEL)?
Key risks for QuidelOrtho Corporation (QDEL) include ongoing losses with negative EPS and profit margins, a high debt-to-equity ratio of 1.73, declining revenue projections, and a bearish long-term technical trend indicated by its position below the 200-day moving average.
How does QDEL's valuation compare to its sector peers?
QuidelOrtho Corporation (QDEL) trades at a price-to-sales ratio of 0.36, which is substantially lower than the sector median of 3.7. However, its profitability metrics, such as net profit margin (-39.20%) and return on equity (-45.91%), are significantly worse than sector averages.
Are insiders buying or selling QuidelOrtho Corporation (QDEL) stock?
Insiders at QuidelOrtho Corporation (QDEL) are net buyers, having purchased $1.2M worth of stock versus $112K in sales. This moderate buying signal, occurring across recent filings, suggests some level of insider confidence in the company's prospects.
Is QDEL in an uptrend?
Not clearly. QuidelOrtho Corporation (QDEL) trades at $13.87, above its 50-day but below its 200-day moving average ($12.98 and $17.34). Its 14-day RSI on daily closes is 62.9, showing bullish momentum without being overbought.
What is the analyst price target for QDEL?
As of October 14, 2026, the 3 Wall Street analysts covering QDEL have 12-month targets from $12.00 to $20.00, with a median of $12.00, 13.5% below the current price of $13.87. 1 rate it a buy or strong buy, 1 a hold and 1 a sell or strong sell. Three months ago 1 of 5 rated it a buy.
What is QDEL's biggest drop in the last 10 years?
QuidelOrtho Corporation (QDEL)'s worst peak-to-trough fall over the last 10 years was -96.3%, from August 2020 to September 2026. It has not regained that peak yet and is still 95.3% below it. Over the same period, 34% of 1-year holding periods ended with a gain.
What are QDEL's best and worst months?
Over the last 10 years, July has been QDEL's strongest month on average (+12.12%, rising in 8 of 10 years) and August its weakest (-6.13%, rising in 3 of 10 years). Seasonal averages describe the past and do not predict a given year.
How closely does QDEL move with the stock market?
Over the past year QDEL's daily returns were weakly correlated with the S&P 500 (SPY) (+0.38). Nasdaq 100 (QQQ): +0.34; Bitcoin (BTC): +0.07; Gold (XAU): +0.06. A figure near +1 means the two usually move together; near 0 means little relationship.
What would $10,000 invested in QDEL be worth today?
$10,000 put into QDEL in October 2016 would be worth about $6,772 today, against about $36,506 for the same amount in the S&P 500.
